Follow-up of Endovascular Aneurysm Treatment - The FEAT Trial
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00281411|
Recruitment Status : Completed
First Posted : January 24, 2006
Last Update Posted : February 15, 2018
After endovascular abdominal aortic aneurysm repair, life-long follow-up is needed to monitor the effectiveness of exclusion of the aneurysm sac from blood flow. For this reason, aneurysm diameter and the presence of endoleaks is evaluated with CT angiography yearly after Endovascular Aneurysm Repair (EVAR).
The aim of this study is to investigate the value of MRA examinations for the follow-up of these patients. The advantages of MRA with respect to CTA are no use of ionizing radiation, use of less nephrotoxic contrast agents.
|Condition or disease||Intervention/treatment|
|Aortic Aneurysm, Abdominal||Procedure: Computed Tomography Angiography Procedure: Magnetic Resonance Angiography|
|Study Type :||Observational|
|Actual Enrollment :||46 participants|
|Official Title:||Follow-up Study of Endovascular Abdominal Aortic Aneurysm Treatment|
|Study Start Date :||March 2001|
|Actual Study Completion Date :||March 2009|
Procedure: Computed Tomography Angiography
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00281411
|Utrecht, Netherlands, 3584 CX|
|Principal Investigator:||W. Mali, MD PhD||UMC Utrecht|